Background Dysthyroid optic neuropathy (DON) is a serious complication of Graves
orbitopathy (GO) from optic nerve dysfunction that may result in permanent loss of vision …

Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage.
Novel therapies have recently emerged, and their specific roles are still being determined …

Background: The use of artificial intelligence (AI) in health care has grown exponentially with
the promise of facilitating biomedical research and enhancing diagnosis, treatment …

Abstract Background In the United States, women are at a higher risk of developing vision
impairment or a serious eye disease (such as age-related macular degeneration, thyroid …

Purpose: To evaluate peripapillary and macular vessel density in eyes with dysthyroid optic
neuropathy (DON) and its correlation with visual function. Methods: Patients diagnosed as …

Anti-inflammatory treatment is the primary and vital therapeutic approach for active,
moderate-to-severe thyroid eye disease (TED). Accurate pretreatment prediction of …

Background This study aimed to establish a deep learning system for detecting the active
and inactive phases of thyroid-associated ophthalmopathy (TAO) using magnetic resonance …

Graves' ophthalmopathy (GO) is an autoimmune disease related to Grave's disease (GD).
The therapeutic strategies for GO patients are based on precise assessment of the activity …

Graves' disease is an autoimmune disorder in which hyperthyroidism results in various
systematic symptoms, with about 30% of patients presenting with Graves' eye disease …

Imaging in thyroid eye disease (TED) is used to exclude other diagnoses, assess for apical
crowding and plan surgery. But to quantify TED activity objectively, subjective clinical …